IRESSA
ASTRAZENECA CANADA INC
Quick answers
Is there a shortage of IRESSA in Canada?
No. There is no current shortage of IRESSA 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-GEFITINIB
APOTEX INC
EUGIA-GEFITINIB
EUGIA PHARMA INC.
AURO-GEFITINIB
AURO PHARMA INC
JAMP GEFITINIB
JAMP PHARMA CORPORATION
DIN
02248676
Strength
250MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from ASTRAZENECA CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
20MG · DIN 02236606
1MG · DIN 02224135
DIN 02518058
0.5MG · DIN 00786616
60MG · DIN 02455005
90MG · DIN 02368544
2MG · DIN 02448610
10MCG · DIN 02361817
5MCG · DIN 02361809
100MG · DIN 02535696
50MG · DIN 02184478
10MG · DIN 02247162